Últimos ensayos

EudraCT Number: 2004-000248-25 Sponsor Protocol Number: CZOL446O2306 Start Date: 2004-08-04
Sponsor Name: Novartis Pharma AG
Full Title: A multinational, multicenter, randomized, double-blind, double-dummy, stratified, active controlled parallel group study comparing the efficacy and safety of intravenous zoledronic acid, 5 mg once ...
Medical condition: corticosteroid induced osteoporosis
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Completed) CZ (Completed) ES (Completed)
Trial results: View results
EudraCT Number: 2004-000985-12 Sponsor Protocol Number: AVA100468 Start Date: 2004-08-03
Sponsor Name: GlaxoSmithKline R&D Limited
Full Title: An open-label extension to study AVA100193, to assess the long-term safety and efficacy of rosiglitazone (extended release tablets) in subjects with mild to moderate Alzheimer's disease.
Medical condition: Mild to moderate Alzheimer's Disease
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Completed) ES (Completed)
Trial results: View results
EudraCT Number: 2004-001197-10 Sponsor Protocol Number: CVAH631C2302 Start Date: 2004-08-03
Sponsor Name: Novartis Pharmaceuticals Corporation
Full Title: A double-blind, randomized, multi-center active-controlled, parallel-group study comparing the combination of valsartan 320 mg plus hydrochlorothiazide 12.5 mg and valsartan 320 mg plus hydrochlor...
Medical condition: Mild to moderate hypertension
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Completed)
Trial results: (No results available)
EudraCT Number: 2004-000243-23 Sponsor Protocol Number: Hx-CD4-109 Start Date: 2004-08-03
Sponsor Name: Genmab A/S
Full Title: An Open-Label Therapeutic Exploratory Clinical Trial of HuMax-CD4, a Fully Human Monoclonal Anti-CD4 Antibody, in Patients with refractory or relapsed Non-Cutaneous CD4+ T-Cell Lymphoma
Medical condition: The mature non-cutaneous T-cell lymphomas expressing the CD4 molecule are the object of this protocol. 1.Peripheral T-cell lymphoma (PTCL) unspecified 2.Angioimmunnoblastic T-cell lymphoma 3.Anapl...
Disease: Version SOC Term Classification Code Term Level
7.0 10042971 LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Completed) DK (Completed)
Trial results: (No results available)
EudraCT Number: 2004-000580-10 Sponsor Protocol Number: H6D-HL-LVGD Start Date: 2004-08-03
Sponsor Name: Oy Eli Lilly Finland Ab
Full Title: Effect of Tadalafil on the Quality of Life and Sexual Life Satisfaction in Erectile Dysfunction (ED) Patients Previously Treated with other Oral ED therapy
Medical condition: Erectile dysfunction
Disease: Version SOC Term Classification Code Term Level
10061461
Population Age: Adults, Elderly Gender: Male
Trial protocol: FI (Completed)
Trial results: View results
EudraCT Number: 2004-001449-13 Sponsor Protocol Number: XM02-04-INT Start Date: 2004-08-03
Sponsor Name: BioGeneriX AG
Full Title: Safety and Efficacy of XM 02 in patients with Non-Hodgkin-Lymphoma receiving chemotherapy.
Medical condition: Patients with Non-Hodgkin-Lymphoma receiving chemotherapy and developing Neutropenia due to chemotherapy.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Completed) LT (Completed)
Trial results: (No results available)
EudraCT Number: 2004-000452-16 Sponsor Protocol Number: 156-03-244 Start Date: 2004-08-02
Sponsor Name: Otsuka Maryland Research Institute
Full Title: International, Multi-Centre, Study of One year, Open Label, Titrated Oral Tolvaptan Tablet Administration in Patients with Chronic Hyponatraemia: Extension to Studies 156-02-235 and 156-03-238 to a...
Medical condition: Ongoing hyponatraemia in euvolemic and hypervolemic states
Disease: Version SOC Term Classification Code Term Level
7 10021036 1.1
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Completed) CZ (Completed) ES (Completed) IT (Completed)
Trial results: View results
EudraCT Number: 2004-000312-93 Sponsor Protocol Number: 0431-020 Start Date: 2004-08-02
Sponsor Name: Merck Sharp & Dohme (Sweden) AB
Full Title: A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of the Addition of MK-0431 to Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metfor...
Medical condition: Type 2 Diabetes Mellitus
Disease: Version SOC Term Classification Code Term Level
7.0 10045242 LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Completed) AT (Completed) DK (Completed) BE (Completed) IT (Completed)
Trial results: View results
EudraCT Number: 2004-001273-26 Sponsor Protocol Number: CASM981CES02 Start Date: 2004-08-02
Sponsor Name: NOVARTIS FARMACEUTICA, S.A
Full Title: A 3 weeks study randomized, multicenter, double blind, vehicle controlled , parallel-group to evaluate the efficacy and safety of Pimecrolimus cream 1% in children between 2 – 11 years with mild to...
Medical condition: Mild to moderate Atopic Dermatitis
Disease: Version SOC Term Classification Code Term Level
7.0 10003641 LLT
Population Age: Children, Under 18 Gender: Male, Female
Trial protocol: ES (Completed)
Trial results: View results
EudraCT Number: 2004-002033-39 Sponsor Protocol Number: PAN 2004-01 Start Date: 2004-08-02
Sponsor Name: AZIENDA OSPEDALIERA SAN GERARDO DI MONZA
Full Title: STUDY OF PREOPERATIVE AND POSTOPERATIVE IL-2 IMMUNOTHERAPY IN PANCREATIC CANCER SURGERY - RANDOMIZED PHASE 2 STUDY
Medical condition: PREVENTION OF IMMUNODEFICENCY IN PANCREATIC CANCER UNDERGOING SURGERY
Disease: Version SOC Term Classification Code Term Level
10062012 PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: (No results available)

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir